Novo Nordisk A/S
NVO
$100.40
-$1.44-1.41%
| Weiss Ratings | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Reward Grade | A+ | |||
| Rating Factors | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.59 | |||
| Price History | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.38% | |||
| 30-Day Total Return | 5.76% | |||
| 60-Day Total Return | 4.24% | |||
| 90-Day Total Return | 30.12% | |||
| Year to Date Total Return | 49.16% | |||
| 1-Year Total Return | 61.05% | |||
| 2-Year Total Return | 92.80% | |||
| 3-Year Total Return | 205.64% | |||
| 5-Year Total Return | 365.65% | |||
| 52-Week High % Change | -5.01% | |||
| 52-Week Low % Change | 60.87% | |||
| Price | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $105.69 | |||
| 52-Week Low Price | $62.41 | |||
| 52-Week Low Price (Date) | Dec 07, 2022 | |||
| 52-Week High Price (Date) | Nov 24, 2023 | |||
| Valuation | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | $454.30B | |||
| Enterprise Value | 451.23B | |||
| Price/Earnings (TTM) | 41.72 | |||
| Earnings Per Share (TTM) | 2.41 | |||
| Earnings Per Share Growth | 42.91% | |||
| Price/Earnings To Growth | 0.97 | |||
| Price/Sales (TTM) | 14.63 | |||
| Price/Book (Q) | 34.08 | |||
| Enterprise Value/Revenue (TTM) | 14.65 | |||
| Price | $101.84 | |||
| Enterprise Value/EBITDA (TTM) | 30.91 | |||
| Enterprise Value/EBIT | 33.47 | |||
| Market Cap Category | Mega Cap | |||
| Dividends and Shares | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 4.489B | |||
| Dividend Yield | 0.73% | |||
| Div. Per Share (Most Recent) | $0.31 | |||
| Dividend Per Share (TTM) | $0.74 | |||
| Payout Ratio (TTM) | 42.45% | |||
| Dividend Per Share (Most Recent) | $0.31 | |||
| Company Info | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 45 44 44 88 88 | |||
| Address | -- | |||
| Website | www.novonordisk.com | |||
| Country | Denmark | |||
| Year Founded | 1923 | |||
| Profitability | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 43.76% | |||
| Profit Margin | 35.19% | |||
| Management Effectiveness | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 22.60% | |||
| Return on Equity | 93.10% | |||
| Income Statement | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | $30.81B | |||
| Total Revenue (TTM) | $30.81B | |||
| Revenue Per Share | $6.86 | |||
| Gross Profit (TTM) | $25.93B | |||
| EBITDA (TTM) | $14.60B | |||
| EBIT (TTM) | $13.48B | |||
| Net Income (TTM) | $10.84B | |||
| Net Income Avl. to Common (TTM) | $10.84B | |||
| Total Revenue Growth (Q YOY) | 38.99% | |||
| Earnings Growth (Q YOY) | 68.26% | |||
| EPS Diluted (TTM) | $2.41 | |||
| EPS Diluted Growth (Q YOY) | 70.09% | |||
| Balance Sheet | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $6.75B | |||
| Cash Per Share (Q) | $1.50 | |||
| Total Current Assets (Q) | $20.17B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | $13.19B | |||
| Current Ratio (Q) | 0.824 | |||
| Book Value Per Share (Q) | $2.95 | |||
| Total Assets (Q) | $42.57B | |||
| Total Current Liabilities (Q) | $24.47B | |||
| Total Debt (Q) | $3.76B | |||
| Total Liabilities (Q) | $29.38B | |||
| Total Common Equity (Q) | $13.19B | |||
| Cash Flow | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -$6.15B | |||
| Cash from Financing (TTM) | -$8.76B | |||
| Net Change in Cash (TTM) | $416.03M | |||
| Levered Free Cash Flow (TTM) | $9.31B | |||
| Cash from Operations (TTM) | $15.43B | |||
